New archers don't know if they will fall in love with shooting a bow or not, so beginner bows are typically a tick cheaper ...

Johnson & Johnson has reported new phase 3 data with its FcRn blocker nipocalimab in generalised myasthenia gravis (gMG), pointing to data that it says differentiates it from other drugs in the class.

Luxury, where the quality of the cabin and the drive experience are as important as day-to-day practicality for what is often ...